Literature DB >> 1997391

Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas.

C L Hanis1, T C Douglas, D Hewett-Emmett.   

Abstract

Apolipoprotein A-IV phenotypes were determined by reprobing immunoblots initially typed for the apolipoprotein E polymorphism on a representative sample of Mexican-Americans from South Texas. Typings on 331 individuals gave frequency estimates of 0.928, 0.066, 0.003, and 0.003 for alleles 1, 2, 3, and 4, respectively. To evaluate the effects of this polymorphic variability on lipid-related measures, mean levels between phenotypes were tested for equality following adjustment for age, sex, and body mass index. Analyses of levels of cholesterol, triglycerides, total high density lipoprotein, and its subfractions, low density lipoprotein, alpha and beta lipoproteins and apolipoproteins A-I, A-II, B, C-II, C-III, and E demonstrate that the A-IV genetic variability contributes minimally to normal variation of these quantitative factors in the population. Examination of the rare types, however, indicates the possibility of large metabolic effects whose follow-up may be useful for elucidating the metabolic roles of apolipoprotein A-IV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997391     DOI: 10.1007/bf00202422

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Lipoprotein and apolipoprotein levels among Mexican-Americans in Starr County, Texas.

Authors:  C L Hanis; D Hewett-Emmett; T C Douglas; W J Schull
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

2.  Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum.

Authors:  L Lagrost; P Gambert; M Boquillon; C Lallemant
Journal:  J Lipid Res       Date:  1989-10       Impact factor: 5.922

Review 3.  DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis.

Authors:  S E Humphries
Journal:  Atherosclerosis       Date:  1988-08       Impact factor: 5.162

4.  The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III.

Authors:  N A Elshourbagy; D W Walker; M S Boguski; J I Gordon; J M Taylor
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

5.  Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator.

Authors:  P J Barter; O V Rajaram; L B Chang; K A Rye; P Gambert; L Lagrost; C Ehnholm; N H Fidge
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

6.  Frequency and effects of the apolipoprotein A-IV polymorphism.

Authors:  S Visvikis; J Steinmetz; E Boerwinkle; R Gueguen; M M Galteau; G Siest
Journal:  Clin Genet       Date:  1990-06       Impact factor: 4.438

7.  Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma.

Authors:  C H Chen; J J Albers
Journal:  Biochim Biophys Acta       Date:  1985-10-02

8.  Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels.

Authors:  H J Menzel; E Boerwinkle; S Schrangl-Will; G Utermann
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

9.  One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV.

Authors:  H J Menzel; R G Kladetzky; G Assmann
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

10.  Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV.

Authors:  A Steinmetz; G Utermann
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

View more
  2 in total

1.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

Authors:  A von Eckardstein; H Funke; M Schulte; M Erren; H Schulte; G Assmann
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  Endothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among Egyptians.

Authors:  Sherif Arafa; Sherehan Abdelsalam; Abdel-Hady El-Gilany; Youssef Mohamed Mosaad; Adel Abdel-Ghaffar
Journal:  Egypt Heart J       Date:  2018-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.